Related Experiment Video
Updated: Apr 7, 2026

Th17 Inflammation Model of Oropharyngeal Candidiasis in Immunodeficient Mice
Published on: February 18, 2015
Oral lichen planus: an update on its pathogenesis
Patrícia A Nogueira1, Sueli Carneiro1, Marcia Ramos-e-Silva1
1Sector of Dermatology, School of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Oral lichen planus (OLP) is a T-cell mediated disease with unknown causes. This review explores OLP pathogenesis, discusses hypotheses, and differentiates it from oral lichenoid lesions.
Area of Science:
- Immunology
- Dermatology
- Oral Medicine
Background:
- Oral lichen planus (OLP) is a prevalent T-cell mediated mucocutaneous condition.
- The precise etiology of OLP remains largely unknown.
- Numerous factors have been implicated in OLP development.
Purpose of the Study:
- To synthesize current understanding of OLP pathogenesis.
- To examine proposed etiological hypotheses for OLP.
- To compare OLP with clinically similar oral lichenoid lesions.
Main Methods:
- Literature review and synthesis of recent research.
- Analysis of proposed etiological factors.
- Comparative study of OLP and oral lichenoid lesions.
Main Results:
- Compilation of current knowledge on OLP pathogenesis.
- Discussion of various hypotheses regarding OLP etiology.
- Identification of key differences and similarities between OLP and oral lichenoid lesions.
Conclusions:
- Further research is needed to elucidate the exact etiology of OLP.
- Understanding pathogenesis is crucial for differentiating OLP from oral lichenoid lesions.
- This review provides a comprehensive overview for clinicians and researchers.
Related Concept Videos
Formation of Lipopolysaccharides
The Oral Microbiota
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Coronary Artery Disease II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.

